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A B S T R A C T
Objective: To determine the intrapartum and perinatal results associated with different degrees of
staining of meconium stained amniotic fluid (MSAF).
Study design: In a retrospective cohort study of all singleton deliveries over a period of one year (2015) in a
tertiary hospital, we compared different degrees of MSAF (yellow, green and thick) to clear amniotic
fluids, and analysed in each group maternal, intrapartum and neonatal variables as well as umbilical cord
blood gas analysis.
Results: Of the 3590 deliveries included, 503 (14%) had MSAF. The incidence of MSAF rises with
gestational age at delivery, reaching 20.7% in gestations above 41 weeks compared to 4.3% below 37
weeks. As the amniotic fluid staining progresses we found a higher proportion of intrapartum fevers
(p < 0.001), pathological fetal heart rate patterns (p < 0.05), operative vaginal deliveries and cesarean
sections (p < 0.001), as well as the need for advanced neonatal resuscitation (p < 0.001). There was also a
correlation between MSAF and low Apgar scores at five minutes (p < 0.001) and fetal-neonatal mortality
(p < 0.001) but there was not a higher proportion of neonatal intensive care admissions (p > 0.05). We
have observed a similar distribution of umbilical artery pH ranges in all groups (p > 0.05).
Conclusions: MSAF was associated with an increase in the rate of pathological fetal heart rate patterns,
intrapartum fevers, operative vaginal and cesarean section deliveries, need for neonatal resuscitation,
low Apgar scores and higher fetal-neonatal mortality. Moreover, we found that the risks increase as the
staining and consistency of the amniotic fluid evolves so it should alert the obstetrician and paediatrician
to the potential adverse outcomes.
© 2018 Published by Elsevier B.V.
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The meconium stained amniotic fluid (MSAF) is observed in
12–16% of deliveries [1]. The intrauterine presence of MSAF may
simply represent the normal gastrointestinal maturation or may
indicate an acute or chronic hypoxic event [2] thereby making it a
warning sign of fetal compromise. Its presence is associated with
an increase in perinatal morbidity and mortality. Higher rates of
stillbirths, low Apgar scores and hypoxic ischemic encephalopathy
have been associated with MSAF [3,4].
It is known that intrapartum and perinatal complications
increase as the staining and consistency of amniotic fluid increases* Corresponding author at: Service of Obstetrics and Gynecology, Vigo University
Hospital Complex, Álvaro Cunqueiro Hospital, Estrada Clara Campoamor n 341,
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Para uso personal exclusivamente. No se permiten otros usos sin autoriz[5]. This way, yellow amniotic fluids are associated with fewer
complications and less morbidity than green ones, and these, in
turn, less than thick amniotic fluids, which leads us to think that
they could be different entities.
The umbilical cord blood gas analysis is an indicator of fetal
hypoxic damage and may provide important information about
the past, the present and possibly the future condition of the
newborn [6].
Therefore, in this study we intend to compare the intrapartum
and perinatal results as well as the umbilical cord blood gas
analysis of the different types of MSAF versus the clear ones.
Materials and methods
A retrospective cohort study was carried out in the University
Hospital Complex of Vigo, a university-affiliated tertiary hospital,
where we analysed all deliveries over a period of one year. The
study included all singleton deliveries after 24 weeks’ gestation
during the year 2015.Sanidade SERGAS de ClinicalKey.es por Elsevier en julio 19, 2018.
ación. Copyright ©2018. Elsevier Inc. Todos los derechos reservados.
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lightly stains the amniotic fluid), green (dark green moderate
staining of the amniotic fluid) and thick (opaque and thick
meconium, also called “pea soup meconium”). Blood-stained
amniotic fluids (BSAF) were considered as a different group, we did
not include it in the MSAF group because they are physiopatho-
logically different. We compared parturients with clear amniotic
fluid (CAF) to those with MSAF and BSAF. The staining of amniotic
fluid was assessed visually at the time of rupture of membranes
and the obstetrician or midwife who attends the delivery
determined the grade of staining. We chose this classification
because it is simple and unifies criteria visually.
Background medical data of pregnant woman and newborn
were collected retrospectively from our electronic health records
and partograms. The Ethical Review Board of the University
Hospital Complex of Vigo approved the data collection for the
study. The following variables were analysed: maternal variables
(age, parity and gestational age), intrapartum variables (onset of
labour, amniotic fluid colour, category of intrapartum fetal heart
rate –FHR-, intrapartum fever and mode of delivery), umbilical
(arterial and venous) cord blood gas analysis (pH, pO2, pCO2, HCO3
and base excess) and neonatal variables (sex, birth weight, Apgar
score, neonatal intensive care admission and need for neonatal
resuscitation).
The gestational age at delivery was established by the last
menstrual period and verified by ultrasonographic gestational age
measurement, if the due date determined by menstrual period
differed from that calculated by ultrasounds (>7 days in the first
trimester, >14 days in the second trimester and >21 days in the
third trimester) then the due date obtained by ultrasound was used
to define gestational age. The amniotic fluid colour was diagnosed
clinically during delivery by the obstetrician or midwife. Electronic
continuous FHR monitoring was used in all parturients from the
beginning of labour or induction to delivery. The FHR category was
established according to the National Institute of Child Health and
Human Development [7]. Intrapartum fever was defined as at least
one axillary temperature measurement of 37.8 C. In our
department, the umbilical cord blood gas analysis is done routinelyTable 1
Study groups (amniotic fluid classification).
n %
CAF 3060 85.2
MSAF 503 14.0
Yelow 208 41.3
Green 277 55.1
Thick 18 3.6
BSAF 27 0.8
TOTAL 3590 100.0
CAF: clear amniotic fluid; MSAF: meconium stained amniotic fluid; BSAF: blood
stained amniotic fluid.
Table 2
Maternal variables (Gestational age & Parity) by amniotic fluid classification.
Gestational age*
<37 w % 37–40 w % 41 w 
CAF 217 93.1 2328 86.1 515 
MSAF 10 4.3 358 13.2 135 
Yelow 2 0.9 144 5.3 62 
Green 8 3.4 202 7.5 67 
Thick 0 0.0 12 0.4 6 
BSAF 6 2.6 19 0.7 2 
TOTAL 233 100 2705 100 652 
CAF: clear amniotic fluid; MSAF: meconium stained amniotic fluid; BSAF: blood staine
* p value 0.000 (Monte Carlo method), considering MSAF as a unique group and as t
** p value 0.000 (Pearson Chi-Square Test), considering MSAF as a unique group and
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with MSAF or BSAF. Apgar score of the newborn was assessed at 1
and 5 min. Resuscitation was considered according to the need
determined by Apgar scoring by the paediatrician and was divided
in superficial (aspiration –grade I-, supplementary O2 –grade II-)
and advanced (CPAP –grade III-, intubation –grade IV-, chest
compression with positive pressure ventilation –grade V-). In our
hospital aspiration (oro-pharyngeal suction) was not systemati-
cally done in all infants born through MSAF, since evidence did not
find a benefit of intrapartum aspiration of the upper airways to
reduce the risk of meconium aspiration syndrome [8]. The
meconium aspiration syndrome is defined as respiratory distress
in newborn infants born through MSAF whose symptoms cannot
be otherwise explained [9], the diagnosis was made by clinical
examination and/or Chest X-Ray.
The statistical analysis was performed using the Statistical
Package for the Social Sciences 19.0 (SPSS Inc., Chicago, IL, USA) and
the statistical software package of R version 3.3.2. The qualitative
variables were analysed by the Pearson chi-square test and the
estimation of p value by Monte Carlo method with R software to
obtain accurate results when the data does not have any of the
underlying assumptions necessary to obtain reliable results with
the Pearson chi-square test. The quantitative variables were
analysed by the Kruskal-Wallis test. Statistical significance was
considered at p value of less than 0.05.
Results
A total of 3590 deliveries were included in this study. Of these,
503 had MSAF (14%): 208 yellow (41.3%), 277 green (55.1%) and 18
thick (3.6%). The BSAF amounted to 0.8% (n = 27) [Table 1]. The
mean maternal age of the study group was 33.2 (range: 15–51), we
have not found relationship between maternal age and amniotic
fluid classification.
We found a higher incidence of MSAF as the weeks of gestation
increased, being significant (p < 0.001) when we studied it at
intervals: 37 weeks (4.3% of MSAF), 37–40 weeks (13.2%) and 41
(20.7%) [Table 2].
We observed a higher significant proportion of MSAF in
primiparous than in multiparous women (64.8% vs. 35.2%)
(p < 0.001) [Table 2].
When we analysed the onset of labour, no differences were
found between the inductions and the spontaneous onset
deliveries (52.2% of MSAF in inductions vs. 47.8% in spontaneous)
(p 0.069) [Table 3]. The amniotic fluids from all planned cesarean
sections (n = 182) were clear.
There were a higher proportion of intrapartum fevers in MSAF
vs. CAF (20.5% vs. 12.4%) (p < 0.001). In addition, the proportion
increased as the colour of the amniotic fluid progresses (12.4% in
CAF, 17.3% in yellow, 20.2% in green and 61.1% in the thick ones).
BSAF presented fever in 11.1% of cases (similar to CAF) [Table 4].Parity**
% Primiparous % Multiparous %
79.0 1673 83.0 1387 88.1
20.7 326 16.2 177 11.2
9.5 124 6.2 84 5.3
10.3 187 9.3 90 5.7
0.9 15 0.7 3 0.2
0.3 16 0.8 11 0.7
100 2015 100 1575 100
d amniotic fluid.
hree different groups.
 as three different groups.
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Table 5
FHR intrapartum category in MSAF & BSAF.
FHR
I % II % III % TOTAL %
MSAF 314 62.4 176 35.0 13 2.6 503 100
Yellow 149 71.6 56 26.9 3 1.4 208 100
Green 157 56.7 111 40.1 9 3.2 277 100
Thick 8 44.4 9 50.0 1 5.6 18 100
BSAF 15 55.6 11 40.7 1 3.7 27 100
TOTAL 329 62.1 187 35.3 14 2.6 530 100
FHR: fetal heart rate; MSAF: meconium stained amniotic fluid; BSAF: blood stained
amniotic fluid
p value 0.021 (Pearson Chi-Square Test) when in the statistical analysis MASF is
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epidural analgesia and the presence of intrapartum fever, when we
analysed the use of epidural and the staining of amniotic fluid we
did not find differences: the percentages of the different MSAF
categories were similar in patients with and without epidural
(p 0.930).
The vast majority of MSAF (78.5%) were vaginal deliveries. We
found an increased risk for operative vaginal delivery and cesarean
section in the presence of MSAF (p < 0.001). It was observed that
the cesarean rate increased with the degree of staining: 16.8% of
caesarean sections in yellow liquids, 22.7% in green and 55.6%
when it was thick (p < 0.001) [Table 4].
We analysed the FHR intrapartum pattern of the patients with
MSAF and BSAF and we observed less categories I FHR patterns and
more categories II and III as the colour of the MSAF fluid progressed
(p 0.021) [Table 5].
Regarding neonatal outcomes, no differences were observed in
the analysis of the different colours of amniotic fluid at different
umbilical artery pH ranges (pH <7.00, 7.00–7.09; 7.09–7.19 and
7.20), all groups presented a similar distribution (p 0.218). In this
analysis we lost 241 cases where we did not have information
about the umbilical artery pH [Table 6]. The values of the umbilical
cord blood gas analysis in all groups are shown in Table 7.
The presence of MSAF was associated with a higher proportion
of Apgar scores <7 at the fifth minute (p < 0.001) but not in the first
minute (p 0.061) [Table 8]. It was also associated with the need for
neonatal resuscitation (p < 0.001) and with a more advanced
neonatal resuscitation (grades III, IV and V) (p < 0.001). A greater
need for advanced neonatal resuscitation was found as theTable 3
Onset of labour (without planned cesarean section) by amniotic fluid classification.
Onset of labour
Spontaneous % Induction % TOTAL %
CAF 1488 51.7 1392 48.3 2880 100
MSAF 240 47.8 262 52.2 502 100
Yellow 92 44.4 115 55.6 207 100
Green 140 50.5 137 49.5 277 100
Thick 8 44.4 10 55.6 18 100
BSAF 9 34.6 17 65.4 26 100
TOTAL 1737 51.0 1671 49.0 3408a 100
CAF: clear amniotic fluid; MSAF: meconium stained amniotic fluid; BSAF: blood
stained amniotic fluid.
p value 0.126 (Pearson Chi-Square Test) when in the statistical analysis MASF is
considered as three different groups.
p value 0.069 (Pearson Chi-Square Test) when in the statistical analysis MASF is
considered as a unique group.
a Planned cesarean sections were excluded (182).
Table 4
Intrapartum variables (Intrapartum fever & Mode of delivery) by amniotic fluid classifi
Intrapartum fever* Mode of delivery**
No % Yes % Normal vaginal % O
CAF 2681 87.6 379 12.4 1724 56.3 7
MSAF 400 79.5 103 20.5 231 45.9 1
Yellow 172 82.7 36 17.3 116 55.8 5
Green 221 79.8 56 20.2 113 40.8 1
Thick 7 38.9 11 61.1 2 11.1 6
BSAF 24 88.9 3 11.1 7 25.9 7
TOTAL 3105 86.5 485 13.5 1962 54.7 9
CAF: clear amniotic fluid; MSAF: meconium stained amniotic fluid; BSAF: blood staine
* p value 0.000 (Monte Carlo method) when in the statistical analysis MASF is conside
statistical analysis MASF is considered as a unique group.
** p value 0.000 (Pearson Chi-Square Test), considering MSAF as a unique group and
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6.9% in green and 22.2% in thick ones) [Table 9].
There was not a higher proportion of neonatal intensive care
admissions in MSAF cases compared to clear ones (9.9% in MSAF vs.
12.3% in CAF) (p 0.260) [Table 8]. The main indication for admission
of neonates with MSAF was respiratory distress (63%).
We have not found a relationship between birthweight and
amniotic fluid classification, the mean birthweight was 3216.4
(range: 420–4910).
There was an association between amniotic fluid colour and
fetal-neonatal mortality (p < 0.001). Mortality in MSAF was 1%
compared to 0.1% in CAF [Table 9]. In our study 3 neonates
presented meconium aspiration syndrome (2 in green fluids and 1
in thick fluids), causing death in 2 of them.cation.
perative vaginal % Cesarean section % TOTAL %
64 25.0 572 18.7 3060 100
64 32.6 108 21.5 503 100
7 27.4 35 16.8 208 100
01 36.5 63 22.7 277 100
 33.3 10 55.6 18 100
 25.9 13 48.1 27 100
35 26.0 693 19.3 3590 100
d amniotic fluid.
red as three different groups. p value 0.000 (Pearson Chi-Square Test) when in the
 as three different groups.
considered as three different groups.
p value 0.757 (Pearson Chi-Square Test) when in the statistical analysis MASF is
considered as a unique group
Table 6
pH ranges in umbilical artery by amniotic fluid classification.
pH
<7.00 % 7.00–7.09 % 7.10–7.19 % 7.20 %
CAF 15 83.3 88 85.4 563 87.6 2192 84.8
MSAF 3 16.7 12 11.7 79 12.3 373 14.4
Yellow 1 5.6 3 2.9 33 5.1 157 6.1
Green 2 11.1 9 8.7 42 6.5 206 8.0
Thick 0 0.0 0 0.0 4 0.6 10 0.4
BSAF 0 0.0 3 2.9 1 0.2 20 0.8
TOTAL 18 100 103 100 643 100 2585 100
CAF: clear amniotic fluid; MSAF: meconium stained amniotic fluid; BSAF: blood
stained amniotic fluid.
p value 0.2186 (Monte Carlo method) when in the statistical analysis MASF is
considered as three different groups.
p value 0.0613 (Monte Carlo method) when in the statistical analysis MASF is
considered as a unique group.
idade SERGAS de ClinicalKey.es por Elsevier en julio 19, 2018.
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Table 7
Cord blood gas analysis, expressed in mean (standard deviation).
Arterial Venous
pH pCO2 HCO3 BE pH pCO2 HCO3 BE
CAF 7.24 (0.074) 51.80 (10.009) 17.93 (2.299) 5.92 (2.817) 7.30 (0.069) 41,59 (8.098) 18.30 (2.224) 6.08 (2.545)
MSAF 7.25 (0.069) 50.95 (9.704) 17.70 (2.317) 6.07 (2.599) 7.28 (0.063) 42.50 (7.693) 17,84 (2.176) 6.47 (2.406)
Yellow 7.24 (0,069) 50.31 (10.104) 17.89 (2.166) 5.93 (2.510) 7.29 (0.064) 42.32 (8.107) 17.99 (2.039) 6.34 (2.317)
Green 7.23 (0.071) 51.49 (9.575) 17.61 (2.430) 6.14 (2.654) 7.28 (0.064) 42.76 (7.538) 17.77 (2.266) 6.52 (2.456)
Thick 7.23 (0.040) 49.79 (4.250) 16.69 (2.027) 6.84 (2.768) 7.27 (0.052) 41.79 (3.867) 16.92 (2.314) 7.14 (2.750)
BSAF 7.24 (0.080) 52.17 (8.791) 18.08 (2.814) 5.63 (3.363) 7.29 (0.060) 43.21 (5.509) 18.39 (2.384) 5.70 (2.868)
p value (Kruskal-Wallis) 0.512 0.000 0.059 0.268 0.000 0.040 0.000 0.008
BE: Base excess.
Table 8
Neonatal variables (Apgar scores & Neonatal care admission) by amniotic fluid classification.
Apgar 1 min* Apgar 5 min** Neonatal care admission*** TOTAL %
<7 %  7 % <7 % 7 % No % Yes %
CAF 27 0.9 3033 99.1 3 0.1 3057 99.9 2685 87.7 375 12.3 3060 100
MSAF 12 2.4 491 97.6 5 1.0 498 99.0 453 90.1 50 9.9 503 100
Yellow 3 1.4 205 98.6 0 0.0 208 100.0 193 92.8 15 7.2 208 100
Green 6 2.2 271 97.8 2 0.7 275 99.3 246 88.8 31 11.2 277 100
Thick 3 16.7 15 83.3 3 16.7 15 83.3 14 77.8 4 22.2 18 100
BSAF 2 7.4 25 92.6 2 7.4 25 92.6 25 92.6 2 7.4 27 100
TOTAL 41 1.1 3549 98.9 10 0.3 3580 99.7 3163 88.1 427 11.9 3590 100
CAF: clear amniotic fluid; MSAF: meconium stained amniotic fluid; BSAF: blood stained amniotic fluid.
* p value 0.000 (Monte Carlo method) when in the statistical analysis MASF is considered as three different groups. p value 0.061 (Pearson Chi-Square Test) when in the
statistical analysis MASF is considered as a unique group.
** p value 0.000 (Monte Carlo method) when in the statistical analysis MASF is considered as a unique group and as three different groups.
*** p value 0.121 (Monte Carlo method) when in the statistical analysis MASF is considered as three different groups. p value 0.260 (Pearson Chi-Square Test) when in the
statistical analysis MASF is considered as a unique group.
Table 9
Neonatal variables (Neonatal resuscitation & Mortality) by amniotic fluid classification.
Resuscitation* Mortality** Total %
No % Superficial % Advanced % No % Yes %
CAF 2110 69.0 868 28.4 82 2.7 3057 99.9 3 0.1 3060 100
MSAF 104 20.7 364 72.4 35 7.0 498 99.0 5 1.0 503 100
Yellow 62 29.8 134 64.4 12 5.8 208 100.0 0 0.0 204 100
Green 40 14.4 218 78.7 19 6.9 275 99.3 2 0.7 281 100
Thick 2 11.1 12 66.7 4 22.2 15 83.3 3 16.7 18 100
BSAF 9 33.3 16 59.3 2 7.4 25 92.6 2 7.4 27 100
TOTAL 2223 61.9 1248 34.8 119 3.3 3580 99.7 10 0.3 3590 100
CAF: clear amniotic fluid; MSAF: meconium stained amniotic fluid; BSAF: blood stained amniotic fluid.
* p value 0.000 (Pearson Chi-Square Test), considering MSAF as a unique group and as three different groups.
** p value 0.000 (Monte Carlo method), considering MSAF as a unique group and as three different groups.
68 V. Rodríguez Fernández et al. / European Journal of Obstetrics & Gynecology and Reproductive Biology 228 (2018) 65–70Comment
The aim of this study was to assess the association between the
different degrees of amniotic fluid staining with intrapartum and
neonatal outcomes. Our main findings were: (1) positive relation
between the rate of MSAF and gestational age at delivery, (2) as the
amniotic fluid staining progresses we have seen a higher
proportion of intrapartum fevers, more pathological FHR patterns,
an increased risk for operative vaginal and cesarean sections
deliveries and a greater need for advanced neonatal resuscitation,
(3) association between MSAF and fetal-neonatal mortality and (4)
similar distribution of umbilical artery pH in all groups.
The exact etiology of MSAF remains unclear. In our study, the
prevalence of MSAF was similar to previous reports. Moreover, in
concordance with prior reports, we have observed that the
incidence of MSAF rises with gestational age at delivery,
reinforcing the theory that MSAF at term is a physiological eventDescargado para Anonymous User (n/a) en Bibliosaude Conselleria de 
Para uso personal exclusivamente. No se permiten otros usos sin autorizthat may reflect the maturity of fetal gastrointestinal tract. The
presence of MSAF is rare before 34 weeks of gestation and the
incidence increases steadily beyond 37 weeks of gestation [10].
Factors such as placental insufficiency, maternal hypertension,
preeclampsia, oligohydramnios or abuse of maternal drugs result
in staining of the amniotic fluid [11]. Despite the fact that MSAF
may represent a physiological event at late gestation, it was still a
risk factor for neonatal complications and especially respiratory
morbidity. Hiersch et al. have found that neonates exposed to
MSAF, who were delivered at early term, were at increased risk for
neonatal intensive care admission and neonatal adverse outcomes
such as neonatal sepsis, jaundice, and low Apgar score compared
with those delivered at full term [12].
The most acceptable theories to explain the passage of
meconium were attributed to the response of the fetus to hypoxia
or a vagal stimulation from umbilical cord compression resulting in
an increased fetal peristalsis. It should be considered as a markerSanidade SERGAS de ClinicalKey.es por Elsevier en julio 19, 2018.
ación. Copyright ©2018. Elsevier Inc. Todos los derechos reservados.
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suggested that meconium has a vasoconstrictive effect on
umbilical vessels, which may explain the increased incidence of
pathological FHR so there is an increased risk for operative vaginal
delivery and cesarean section, as found in our study. MSAF was also
found to be associated with subclinical inflammatory processes,
considering it as a risk factor of microbial infection of the amniotic
cavity [14,15]. The incidence of MSAF and neonatal morbidity was
shown to be higher in the presence of inflammation of placental
membranes [16]. Our study found an association between the
presence of MSAF and intrapartum fever, supporting the view that
the presence of MSAF should be an alert of potential infection and
increased neonatal morbidity.
An association of MSAF with maternal ingestion of certain drugs
and herbal remedies during pregnancy has been suggested but not
very investigated. Meconium passagewas foundto be morecommon
in women who had recently taken castor oil (a fatty bland oil
contrainticated during pregnancy but still recommended by some
for labour induction, it causes rapid evacuation of bowel contents as
well as uterine contractions) and herbal sustances called “sihlam-
bezo” (widespread use in south Africa) [17]. According to Chitrakar
[18], a 25 mg intravaginal misoprostol reduces meconium passage
and MSAF was found more in the inductions with dinoprostone. The
use of laxative or enemas, which were suggested, was not associated
with meconium passage [17].
In agreement with previous reports [19], we found an
increased rate of neonatal complications in the presence of
MSAF: low Apgar scores, a need for advanced resuscitation and
fetal-neonatal mortality. Most neonatal adverse outcomes
observed, like in others reports, were related to pulmonary
pathology: respiratory distress and the need for ventilator
support as well as the meconium aspiration syndrome.
Meconium was found to cause umbilical cord vascular necrosis
and also to be toxic to fetal lung (causing obstruction of
airways, chemical pneumonitis, vasoconstriction of pulmonary
vessels, and inactivation of surfactant) [20]. Despite the
increase in neonatal complications observed, no differences
have been found in umbilical artery pH between groups, which
is an objective measure of neonatal condition. Respiratory
acidosis was not observed, so there were no cases of neonatal
asphyxia or it was metabolically compensated at the time of its
measurement.
An interesting matter is the clinical significance of the change in
colour of amniotic fluid, from clear to meconium (secondary
meconium), and the different prognosis between it and primary
meconium (MSAF noted at the time of membranes rupture). While
primary meconium seems to be more related with fetal matura-
tion, secondary meconium is more likely to reflect intrapartum
fetal distress. However, only few studies distinguished between
primary and secondary meconium and supported the importance
of distinction between them with respect to the increased risk for
adverse outcomes in the secondary: low 5-min Apgar score,
neonatal intensive care admission, umbilical artery pH < 7,1 and
intrapartum cesarean section [21,22].
Another interesting question is, what is the significance of the
transformation from CAF to yellow, green and finally thick fluid,
and whether the outcome in these different cases of MSAF is
different. Our study demonstrates that the risks increase as the
colour and consistency of the amniotic fluid evolves. However, this
is the first study that compares and separates the different types of
MSAF. Past reports suggested that the “thickness” of meconium
had a direct bearing on the neonatal outcome, showing that
incidence of birth asphyxia was significantly higher in thick
meconium compared to thin meconium [23].
Therefore, where does MSAF come from? Recently, it has been
documented that in-utero defecation occurs throughout fetal lifeDescargado para Anonymous User (n/a) en Bibliosaude Conselleria de San
Para uso personal exclusivamente. No se permiten otros usos sin autorizacióas a physiologic function during fetal development [24]. The
intestinal content in the fetus (meconium) is of a greenish colour,
which results from the accumulation of the bile pigments [25].
However, as the basic theories and recent reports assert [26,27], it
emerges as a clear fluid because there is a balance in the fetal
circuits of swallowing, urination and respiratory tract secretion. If
the balance is broken, the amniotic fluid will be stained, probably
related to a biochemical change in the bilirubin oxidation system,
responsible for biliverdin formation (main component that gives
the greenish colour of meconium).
The limitations of our study were mainly due to its retrospective
design. Perhaps certain management decisions and interventions
triggered by the observation of MSAF may affect outcomes and thus
bias the apparent association of MSAF with these outcomes:
increased operative vaginal delivery and cesarean section may be
due to the perception of caregivers that MSAF is a sign of fetal
compromise, rather than an effect of the MSAF per se. Additionally, a
paediatrician is always present in deliveries with MSAF and that
could have biased the Apgar scores assesments. Moreover, other
potential confounders for adverse pregnancy outcome, such as the
rate of maternal obesity, maternal diseases, gestational diseases and
toxic habits were not analysed. However, the strengths of our study
lie on its large cohort and the available data regarding intrapartum
and neonatal outcomes. In addition, our study represents the first
study that emphasizes the importance of distinction between the
different stains of the amniotic fluid due to its significance on
obstetrical and neonatal outcome.
In conclusion, our study shows that the presence of MSAF is
associated with an increase in the rate of pathological FHR
patterns, intrapartum fevers, low Apgar scores and is associated
with higher fetal-neonatal mortality. In order to reduce perinatal
morbidity and mortality, the presence of MSAF requires intensive
FHR monitoring and a certain clinical performance depending on
the type of MSAF as we have shown that the obstetrical and
perinatal complications increase with the degree of amniotic fluid
staining and consistency. The fact of having lower Apgar scores and
a greater need for advanced resuscitation leads to an immediate
and proper pediatric assessment.
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